Cytarabine and Bone marrow toxicity - a phase IV clinical study of FDA data

Summary:

Bone marrow toxicity is reported as a side effect among people who take Cytarabine (cytarabine), especially for people who are male, 0-1 old, have been taking the drug for 1 - 6 months also take Methotrexate, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Bone marrow toxicity when taking Cytarabine. It is created by eHealthMe based on reports of 65,319 people who have side effects when taking Cytarabine from the FDA, and is updated regularly.

What is Cytarabine?

Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. eHealthMe is studying from 65,358 Cytarabine users. Check the latest studies of Cytarabine.

What is Bone marrow toxicity?

Bone marrow toxicity (decrease in cells responsible for providing immunity, carrying oxygen, and those responsible for normal blood clotting) is found to be associated with 170 drugs and 376 conditions by eHealthMe. Check the latest studies of Bone marrow toxicity.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

65,319 people reported to have side effects when taking Cytarabine.
Among them, 41 people (0.06%) have Bone marrow toxicity.

Could Cytarabine cause Bone marrow toxicity?

Among these 41 people:

How long have people been on Cytarabine when they have Bone marrow toxicity? *

What is the gender of people who have Bone marrow toxicity when taking Cytarabine? *

female: 10.71 %
male: 89.29 %

What is the age of people who have Bone marrow toxicity when taking Cytarabine? *

What are other drugs people take besides Cytarabine? *

What are other side effects people have besides Bone marrow toxicity? *

Pneumonia: 7 people, 17.07%
Thrombocytopenia (decrease of platelets in blood): 7 people, 17.07%
Infection: 6 people, 14.63%
Nausea (feeling of having an urge to vomit): 6 people, 14.63%
Mucosal Inflammation (infection of mucous membrane): 5 people, 12.20%
Nephropathy Toxic (damage to kidney due to toxins): 5 people, 12.20%
Febrile Neutropenia (fever with reduced white blood cells): 5 people, 12.20%
Diarrhea: 4 people, 9.76%
Disease Progression: 4 people, 9.76%
Nausea And Vomiting: 4 people, 9.76%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 14 people, 34.15%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 12.20%
B Precursor Type Acute Leukaemia (lymphoid cancer): 4 people, 9.76%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 7.32%
Lymphoma (cancer that begins in immune system cells): 2 people, 4.88%
Bone Marrow Conditioning Regimen: 2 people, 4.88%
Central Nervous System Lymphoma (cancer of central nervous system forms in lymph tissue): 2 people, 4.88%
Testis Cancer (testes cancer): 1 person, 2.44%
Burkitt's Lymphoma Recurrent (recurrent blood cancer): 1 person, 2.44%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 2.44%

* Approximation only. Some reports may have incomplete information.

Do you take Cytarabine and have Bone marrow toxicity?

- Check whether Bone marrow toxicity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cytarabine:

Cytarabine (65,358 reports)

Browse all side effects of Cytarabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bone marrow toxicity:

Bone marrow toxicity (170 drugs)

Browse all the conditions that are associated with Bone marrow toxicity:

Bone marrow toxicity (376 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cytarabine (the active ingredients of Cytarabine) and Cytarabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.